• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤中的细胞因子:从发病机制到治疗。

Cytokines in neuroblastoma: from pathogenesis to treatment.

机构信息

Laboratory of Oncology, G Gaslini Institute, Largo G Gaslini 5, 16148 Genova, Italy.

出版信息

Immunotherapy. 2011 Jul;3(7):895-907. doi: 10.2217/imt.11.80.

DOI:10.2217/imt.11.80
PMID:21751957
Abstract

Cytokines released by cancer cells or by cells of the tumor microenvironment stimulate angiogenesis, act as autocrine or paracrine growth factors for malignant cells, promote tumor cell migration and metastasis or create an immunosuppressive microenvironment. These tumor-promoting effects of cytokines also apply to neuroblastoma (NB), a pediatric neuroectodermal malignancy with frequent metastatic presentation at diagnosis and poor prognosis. IL-6 and VEGF are the best characterized cytokines that stimulated tumor growth and metastasis, while others such as IFN-γ can exert anti-NB activity by inducing tumor cell apoptosis and inhibiting angiogenesis. On the other hand, cytokines are part of the anti-NB therapeutic armamentarium, as exemplified by IL-2 and granulocyte-macrophage colony stimulating factor that potentiate the activity of anti-NB antibodies. These recent results raise hope for more efficacious treatment of this ominous pediatric malignancy.

摘要

癌细胞或肿瘤微环境中的细胞释放的细胞因子刺激血管生成,作为自分泌或旁分泌生长因子作用于恶性细胞,促进肿瘤细胞迁移和转移,或形成免疫抑制微环境。这些细胞因子的促肿瘤作用也适用于神经母细胞瘤(NB),这是一种儿童神经外胚层恶性肿瘤,在诊断时经常发生转移,预后不良。IL-6 和 VEGF 是最具特征性的细胞因子,可刺激肿瘤生长和转移,而干扰素-γ(IFN-γ)等其他细胞因子则通过诱导肿瘤细胞凋亡和抑制血管生成发挥抗 NB 活性。另一方面,细胞因子是抗 NB 治疗手段的一部分,例如白细胞介素-2(IL-2)和粒细胞-巨噬细胞集落刺激因子(GM-CSF)可增强抗 NB 抗体的活性。这些最新的研究结果为治疗这种凶险的儿科恶性肿瘤带来了更有效的希望。

相似文献

1
Cytokines in neuroblastoma: from pathogenesis to treatment.神经母细胞瘤中的细胞因子:从发病机制到治疗。
Immunotherapy. 2011 Jul;3(7):895-907. doi: 10.2217/imt.11.80.
2
Immunogenicity of human neuroblastoma.人类神经母细胞瘤的免疫原性。
Ann N Y Acad Sci. 2004 Dec;1028:69-80. doi: 10.1196/annals.1322.008.
3
Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy.人源增殖γδ-T细胞对神经母细胞瘤的免疫反应表明Vδ1+亚群适用于基于γδ-T细胞的免疫疗法。
J Immunother. 2008 Nov-Dec;31(9):896-905. doi: 10.1097/CJI.0b013e31818955ad.
4
Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.间质干细胞衍生的白细胞介素-6 和血管内皮生长因子促进乳腺癌细胞迁移。
J Cell Biochem. 2012 Nov;113(11):3363-70. doi: 10.1002/jcb.24212.
5
Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma.在播散性神经母细胞瘤中,采用临床规模富集的人γδ T细胞、hu14.18抗体和免疫细胞因子Fc-IL7进行联合免疫治疗。
Clin Cancer Res. 2005 Dec 1;11(23):8486-91. doi: 10.1158/1078-0432.CCR-05-1184.
6
The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts.抗血管内皮生长因子(VEGF)抗体贝伐单抗能有效降低高危神经母细胞瘤异种移植瘤的生长速率。
Pediatr Res. 2006 Nov;60(5):576-81. doi: 10.1203/01.pdr.0000242494.94000.52. Epub 2006 Sep 20.
7
Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.抗体靶向超抗原疗法可诱导人结肠癌中的肿瘤浸润淋巴细胞、过量细胞因子产生及细胞凋亡。
Eur J Immunol. 1996 Jan;26(1):1-9. doi: 10.1002/eji.1830260102.
8
Targeted immunotherapy for high-risk neuroblastoma--the role of monoclonal antibodies.针对高危神经母细胞瘤的靶向免疫治疗——单克隆抗体的作用。
Ann Pharmacother. 2013 Feb;47(2):210-8. doi: 10.1345/aph.1R353. Epub 2013 Feb 5.
9
The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.GD2特异性单克隆抗体14G2a可诱导IMR-32人神经母细胞瘤细胞凋亡并增强化疗药物的细胞毒性。
Cancer Lett. 2009 Aug 28;281(2):171-82. doi: 10.1016/j.canlet.2009.02.040. Epub 2009 Mar 31.
10
GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.针对GD2的免疫疗法及循环微小RNA在神经母细胞瘤中的潜在价值。
J Cell Physiol. 2018 Feb;233(2):866-879. doi: 10.1002/jcp.25793. Epub 2017 May 23.

引用本文的文献

1
Role of Genetic Polymorphisms -238 G>A and -308 G>A, and Serum TNF-α Levels in a Cohort of Mexican Pediatric Neuroblastoma Patients: Preliminary Study.遗传多态性-238 G>A 和-308 G>A 及血清 TNF-α 水平在墨西哥儿科神经母细胞瘤患者队列中的作用:初步研究。
Int J Mol Sci. 2024 Oct 1;25(19):10590. doi: 10.3390/ijms251910590.
2
Opaganib Downregulates N-Myc Expression and Suppresses In Vitro and In Vivo Growth of Neuroblastoma Cells.奥帕加尼布下调N-Myc表达并抑制神经母细胞瘤细胞的体外和体内生长。
Cancers (Basel). 2024 May 5;16(9):1779. doi: 10.3390/cancers16091779.
3
Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions.
革新小儿神经母细胞瘤治疗:揭示精准干预的新分子靶点。
Front Cell Dev Biol. 2024 Mar 27;12:1353860. doi: 10.3389/fcell.2024.1353860. eCollection 2024.
4
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative.靶向 USP-7 的新型氟代 5-吡唑基脲衍生物。
Int J Mol Sci. 2023 May 24;24(11):9200. doi: 10.3390/ijms24119200.
5
Targeting EP2 receptor with multifaceted mechanisms for high-risk neuroblastoma.针对高危神经母细胞瘤的多靶点 EP2 受体治疗。
Cell Rep. 2022 Jun 21;39(12):111000. doi: 10.1016/j.celrep.2022.111000.
6
Biological evaluation of pyrazolyl-urea and dihydro-imidazo-pyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma.吡唑基脲和二氢咪唑并吡唑基脲衍生物作为治疗神经母细胞瘤潜在抗血管生成剂的生物学评价
Oncotarget. 2020 Sep 15;11(37):3459-3472. doi: 10.18632/oncotarget.27733.
7
Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2.低CD4⁺/CD25⁺/CD127⁻调节性T细胞水平和高INF-γ水平与长期输注ch14.18/CHO联合白细胞介素-2治疗的神经母细胞瘤患者生存率提高相关。
Oncoimmunology. 2019 Sep 8;8(12):1661194. doi: 10.1080/2162402X.2019.1661194. eCollection 2019.
8
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.嵌合抗体14.18联合粒细胞-巨噬细胞集落刺激因子、白细胞介素-2和异维甲酸用于高危神经母细胞瘤患者清髓治疗后的综合安全性试验:儿童肿瘤协作组研究ANBL0931
Front Immunol. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355. eCollection 2018.
9
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model.在人神经母细胞瘤临床前模型中,贝伐单抗介导的肿瘤血管重塑改善了GD2嵌合抗原受体T细胞(GD2-CAR T细胞)的肿瘤浸润及抗肿瘤疗效。
Oncoimmunology. 2017 Oct 4;7(1):e1378843. doi: 10.1080/2162402X.2017.1378843. eCollection 2017.
10
Elevated TIMP-1 expression is associated with a prometastatic phenotype, disease relapse, and poor survival in neuroblastoma.组织金属蛋白酶抑制因子-1(TIMP-1)表达升高与神经母细胞瘤的促转移表型、疾病复发及生存率低相关。
Oncotarget. 2017 Jul 28;8(47):82609-82620. doi: 10.18632/oncotarget.19664. eCollection 2017 Oct 10.